The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?
about
Parkinson's disease: from monogenic forms to genetic susceptibility factorsGenetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation updateTen years and counting: moving leucine-rich repeat kinase 2 inhibitors to the clinicNeuropsychiatric characteristics of GBA-associated Parkinson disease.The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study.Gait dynamics in Parkinson's disease: common and distinct behavior among stride length, gait variability, and fractal-like scaling.Efficient Estimation of Nonparametric Genetic Risk Function with Censored Data.LRRK2 G2019S Mutation: Prevalence and Clinical Features in Moroccans with Parkinson's Disease.Lrrk2 R1441G-related Parkinson's disease: evidence of a common founding event in the seventh century in Northern SpainLRRK2 mutations and risk variants in Japanese patients with Parkinson's diseaseGenome-wide mapping of IBD segments in an Ashkenazi PD cohort identifies associated haplotypes.LRRK2 mutations in Parkinson's disease: confirmation of a gender effect in the Italian populationParkinson's disease: Exit toxins, enter geneticsClinical expression of LRRK2 G2019S mutations in the elderly.Nonmotor symptoms in LRRK2 G2019S associated Parkinson's diseaseWearability assessment of a wearable system for Parkinson's disease remote monitoring based on a body area network of sensorsThe genetics of Parkinson disease.Gender differences in the risk of familial parkinsonism: beyond LRRK2?Interest in genetic testing in Ashkenazi Jewish Parkinson's disease patients and their unaffected relativesHigher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysis.Decreased expression of B cell related genes in leukocytes of women with Parkinson's disease.Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in the LRRK2 geneAge-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 Consortium.Novel recruitment strategy to enrich for LRRK2 mutation carriersLower cognitive performance in healthy G2019S LRRK2 mutation carriers.Risk factors for Parkinson's disease may differ in men and women: an exploratory study.OPTN 691_692insAG is a founder mutation causing recessive ALS and increased risk in heterozygotes.Leucine-rich repeat kinase 2 mutations and Parkinson's disease: three questions.Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations.Mood and cognition in leucine-rich repeat kinase 2 G2019S Parkinson's disease.Feasibility study of a wearable system based on a wireless body area network for gait assessment in Parkinson's disease patientsEstimation of genetic risk function with covariates in the presence of missing genotypes.A cognitive fMRI study in non-manifesting LRRK2 and GBA carriers.The relevance of gender in Parkinson's disease: a review.Clinical Features of LRRK2 Carriers with Parkinson's Disease.Motor phenotype of LRRK2-associated Parkinson's disease: a Tunisian longitudinal study.Parkinson's Disease Prevalence and Proximity to Agricultural Cultivated Fields.A homozygous mutation in SLC1A4 in siblings with severe intellectual disability and microcephaly.Arm swing as a potential new prodromal marker of Parkinson's disease.Sex differences in the prevalence of genetic mutations in FTD and ALS: A meta-analysis.
P2860
Q22242870-D67BAAEB-ED54-41FE-B054-FECF268BC00BQ22252904-2529EC01-EC4C-4E66-A7CB-178BA17F1F73Q27007413-3E179CB0-06B5-476B-AC56-5BD3AB58FF09Q30275630-C37B0174-1B57-4969-9269-1833BFD70404Q30440660-C9A29F1D-E66A-4C6F-BDBF-E9CEAF20D59CQ30481214-4601AEAF-26A3-4420-8D27-4A49A231F844Q30998396-4217DA74-F15C-443F-BCDE-AA939F61BF5EQ33561039-E35DB765-9751-463A-8CF1-8CB933F003ADQ33649391-626C395C-2A99-4A6F-9F31-E0C70026F321Q33682480-D0B1EACF-EB03-4AA6-81A2-7A60D747F548Q33991709-8BADC005-1E95-4A12-8A7C-5AEFEED3BB23Q34089529-BA74DB72-7FD0-4947-A9DB-BBE7F7996BA6Q34140428-32B1E180-937D-41D4-A139-7CD4DDFAF45CQ34300290-FB5447F6-85FF-4351-BDDF-A2671FBDF8B3Q34361735-AC5A127F-0EAF-45C0-9A6B-F7073177D6EAQ34398041-23109915-104A-45CD-8B2B-9CDD799FE9EDQ34604083-3926FC9E-9C7C-41D7-87E9-B470971F9BACQ35037102-DC9C03FC-9241-4B3D-9CE0-CEB0B2CB14CBQ35091479-B1B9013A-613A-441E-BC19-C69596DF37B5Q35195815-A3FD361A-3A53-47DB-BE9E-D66FB7036FACQ35290033-6BACC738-7901-4332-9ADF-7F06A8FF6F00Q35772821-9D296FAA-5005-4DA1-958B-B2C401A70D50Q35850713-B6E170CB-B25B-4161-A049-35197EBCC070Q36098631-1B1A17FF-23A3-4FFD-BDF6-73EF5F322232Q36198611-7C5BFDFD-C183-47CF-B4EC-A7ED57C7259EQ36335715-EC408878-16F7-4D66-91F0-2D4AF10E7838Q36638834-AA32CF65-BA24-4FE8-848E-1BDA91A0671AQ37225356-AD3F7148-C99D-4A44-B23C-EA5E8839319BQ37385032-7BAF0CC7-E5FF-4D3A-9F68-77DED393E04FQ37679384-455D971D-3AA0-4783-A19F-84AE06800A0BQ37731033-4AEB4710-F78F-4DD1-B5C1-B78A3F6C3652Q38665765-688B8603-194E-43E6-829D-C5510D950357Q38843010-8D1F5A87-F047-4028-AE7A-3D4980D2AA6EQ39039214-49F61C48-FBB1-45AE-9B8B-0FA5BF7B7917Q39206423-AF187D7D-54EC-4347-8E38-184FF87EE728Q39288784-EB38058F-E30A-4CD9-8A40-6F79D1947656Q40552512-E1B2810B-B5DF-4F11-973B-64BE799D038DQ40990579-0CEB19F2-7891-4296-8C11-009C00BB1FE3Q41355527-4684C780-8959-42F9-AEB6-66FEDFDC6B2BQ42690940-752EF2F0-CDDB-4B74-B988-06B05FC8B5F7
P2860
The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The LRRK2 G2019S mutation in A ...... ase: is there a gender effect?
@ast
The LRRK2 G2019S mutation in A ...... ase: is there a gender effect?
@en
The LRRK2 G2019S mutation in A ...... ase: is there a gender effect?
@nl
type
label
The LRRK2 G2019S mutation in A ...... ase: is there a gender effect?
@ast
The LRRK2 G2019S mutation in A ...... ase: is there a gender effect?
@en
The LRRK2 G2019S mutation in A ...... ase: is there a gender effect?
@nl
prefLabel
The LRRK2 G2019S mutation in A ...... ase: is there a gender effect?
@ast
The LRRK2 G2019S mutation in A ...... ase: is there a gender effect?
@en
The LRRK2 G2019S mutation in A ...... ase: is there a gender effect?
@nl
P2093
P1433
P1476
The LRRK2 G2019S mutation in A ...... ase: is there a gender effect?
@en
P2093
A Bar-Shira
D Bercovich
H Yagev-More
T Gurevich
U Rozovski
P304
P356
10.1212/01.WNL.0000277637.33328.D8
P407
P577
2007-10-01T00:00:00Z